• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[德国国家队列研究(GNC,NAKO健康研究)中自我报告的心血管和代谢疾病评估:方法与初步结果]

[Assessment of self-reported cardiovascular and metabolic diseases in the German National Cohort (GNC, NAKO Gesundheitsstudie): methods and initial results].

作者信息

Jaeschke Lina, Steinbrecher Astrid, Greiser Karin Halina, Dörr Marcus, Buck Thomas, Linseisen Jakob, Meisinger Christa, Ahrens Wolfgang, Becher Heiko, Berger Klaus, Braun Bettina, Brenner Hermann, Castell Stefanie, Fischer Beate, Franzke Claus-Werner, Gastell Sylvia, Günther Kathrin, Hoffmann Wolfgang, Holleczek Bernd, Jagodzinski Annika, Kaaks Rudolf, Kluttig Alexander, Krause Gérard, Krist Lilian, Kuß Oliver, Lehnich Anna-Therese, Leitzmann Michael, Lieb Wolfgang, Löffler Markus, Michels Karin B, Mikolajczyk Rafael, Peters Annette, Schikowski Tamara, Schipf Sabine, Schmidt Börge, Schulze Matthias, Völzke Henry, Willich Stefan N, Pischon Tobias

机构信息

Forschergruppe Molekulare Epidemiologie, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Robert-Rössle-Straße 10, 13125, Berlin, Deutschland.

Abteilung Epidemiologie von Krebserkrankungen, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):439-451. doi: 10.1007/s00103-020-03108-9.

DOI:10.1007/s00103-020-03108-9
PMID:32157352
Abstract

BACKGROUND

Data on self-reported cardiovascular and metabolic diseases are available for the first 100,000 participants of the population-based German National Cohort (GNC, NAKO Gesundheitsstudie).

OBJECTIVES

To describe assessment methods and the frequency of self-reported cardiovascular and metabolic diseases in the German National Cohort.

MATERIALS AND METHODS

Using a computer-based, standardized personal interview, 101,806 participants (20-75 years, 46% men) from 18 nationwide study centres were asked to use a predefined list to report medical conditions ever diagnosed by a physician, including cardiovascular or metabolic diseases. For the latter, we calculated sex-stratified relative frequencies and compared these with reference data.

RESULTS

With regard to cardiovascular diseases, 3.5% of men and 0.8% of women reported to have ever been diagnosed with a myocardial infarction, 4.8% and 1.5% with angina pectoris, 3.5% and 2.5% with heart failure, 10.1% and 10.4% with cardiac arrhythmia, 2.7% and 1.8% with claudicatio intermittens, and 34.6% and 27.0% with arterial hypertension. The frequencies of self-reported diagnosed metabolic diseases were 8.1% and 5.8% for diabetes mellitus, 28.6% and 24.5% for hyperlipidaemia, 7.9% and 2.4% for gout, and 10.1% and 34.3% for thyroid diseases. Observed disease frequencies were lower than reference data for Germany.

CONCLUSIONS

In the German National Cohort, self-reported cardiovascular and metabolic diseases diagnosed by a physician are assessed from all participants, therefore representing a data source for future cardio-metabolic research in this cohort.

摘要

背景

基于人群的德国国民队列(GNC,NAKO健康研究)的前100,000名参与者有自我报告的心血管和代谢疾病数据。

目的

描述德国国民队列中自我报告的心血管和代谢疾病的评估方法及频率。

材料与方法

通过基于计算机的标准化个人访谈,来自18个全国性研究中心的101,806名参与者(20 - 75岁,46%为男性)被要求使用预定义列表报告曾被医生诊断的疾病情况,包括心血管或代谢疾病。对于后者,我们计算了按性别分层的相对频率,并将其与参考数据进行比较。

结果

关于心血管疾病,3.5%的男性和0.8%的女性报告曾被诊断为心肌梗死,4.8%和1.5%曾患心绞痛,3.5%和2.5%曾患心力衰竭,10.1%和10.4%曾患心律失常,2.7%和1.8%曾患间歇性跛行,34.6%和27.0%曾患动脉高血压。自我报告的已诊断代谢疾病的频率分别为糖尿病8.1%和5.8%,高脂血症28.6%和24.5%,痛风7.9%和2.4%,甲状腺疾病10.1%和34.3%。观察到疾病频率低于德国的参考数据。

结论

在德国国民队列中,所有参与者均接受了由医生诊断的自我报告的心血管和代谢疾病评估,因此是该队列未来心脏代谢研究的一个数据源。

相似文献

1
[Assessment of self-reported cardiovascular and metabolic diseases in the German National Cohort (GNC, NAKO Gesundheitsstudie): methods and initial results].[德国国家队列研究(GNC,NAKO健康研究)中自我报告的心血管和代谢疾病评估:方法与初步结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):439-451. doi: 10.1007/s00103-020-03108-9.
2
[Self-reported cancer in the German National Cohort (NAKO Gesundheitsstudie): assessment methods and first results].[德国国家队列研究(NAKO健康研究)中的自我报告癌症:评估方法与初步结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):385-396. doi: 10.1007/s00103-020-03113-y.
3
[Self-reported infections in the German National Cohort (GNC) in the context of the current research landscape].[在当前研究背景下德国国民队列(GNC)中的自我报告感染情况]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):404-414. doi: 10.1007/s00103-020-03114-x.
4
[Assessing incident cardiovascular and metabolic diseases in epidemiological cohort studies in Germany].[在德国的流行病学队列研究中评估心血管和代谢疾病的发病情况]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Apr;61(4):420-431. doi: 10.1007/s00103-018-2712-4.
5
Framework and baseline examination of the German National Cohort (NAKO).德国国家队列研究(NAKO)的框架和基线检查。
Eur J Epidemiol. 2022 Oct;37(10):1107-1124. doi: 10.1007/s10654-022-00890-5. Epub 2022 Oct 19.
6
Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.德国普通人群中的抗核自身抗体:多中心人群研究的患病率及与特定心血管和代谢紊乱的无关联性
Arthritis Res Ther. 2017 Jun 6;19(1):127. doi: 10.1186/s13075-017-1338-5.
7
[Socio-demographic and employment-related factors in the German National Cohort (GNC; NAKO Gesundheitsstudie)].[德国国民队列研究(GNC;NAKO健康研究)中的社会人口学因素和与就业相关的因素]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):267-278. doi: 10.1007/s00103-020-03098-8.
8
[The baseline assessment of the German National Cohort (NAKO Gesundheitsstudie): participation in the examination modules, quality assurance, and the use of secondary data].[德国国家队列研究(NAKO健康研究)的基线评估:参与检查模块、质量保证及二次数据的使用]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):254-266. doi: 10.1007/s00103-020-03093-z.
9
Test-retest reliability of an infectious disease questionnaire and evaluation of self-assessed vulnerability to infections : findings of Pretest 2 of the German National Cohort.传染病调查问卷的重测信度及自我评估感染易感性的评价:德国国民队列预测试2的结果
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Nov;57(11):1300-7. doi: 10.1007/s00103-014-2045-x.
10
[Nighttime transportation noise annoyance in Germany: personal and regional differences in the German National Cohort Study].[德国夜间交通噪音烦恼:德国国民队列研究中的个人和地区差异]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):332-343. doi: 10.1007/s00103-020-03094-y.

引用本文的文献

1
Sex Differences in the Relationship of Socioeconomic Position With Cardiovascular Disease, Cardiovascular Risk Factors, and Estimated Cardiovascular Disease Risk: Results of the German National Cohort.社会经济地位与心血管疾病、心血管危险因素及估计的心血管疾病风险之间关系的性别差异:德国国民队列研究结果
J Am Heart Assoc. 2025 Mar 4;14(5):e038708. doi: 10.1161/JAHA.124.038708. Epub 2025 Feb 25.
2
Epidemiology of metabolic syndrome.代谢综合征的流行病学
Pflugers Arch. 2025 May;477(5):669-680. doi: 10.1007/s00424-024-03051-7. Epub 2025 Jan 25.
3
Differences in Anthropometric Measures Based on Sex, Age, and Health Status: Findings From the German National Cohort (NAKO).

本文引用的文献

1
Regional Differences in the Prevalence of Cardiovascular Disease.心血管疾病患病率的地区差异。
Dtsch Arztebl Int. 2016 Oct 21;113(42):704-711. doi: 10.3238/arztebl.2016.0704.
2
The Prevalence and Incidence of Diabetes in Germany.德国糖尿病的患病率和发病率。
Dtsch Arztebl Int. 2016 Mar 18;113(11):177-82. doi: 10.3238/arztebl.2016.0177.
3
Trends in disease burden in Germany: results, implications and limitations of the Global Burden of Disease study.德国疾病负担趋势:全球疾病负担研究的结果、影响及局限性
基于性别、年龄和健康状况的人体测量指标差异:德国国家队列(NAKO)的研究结果。
Dtsch Arztebl Int. 2024 Apr 5;121(7):207-213. doi: 10.3238/arztebl.m2024.0016.
4
Chronic disease outcome metadata from German observational studies - public availability and FAIR principles.德国观察性研究的慢性病结局元数据 - 公开可用性和 FAIR 原则。
Sci Data. 2023 Dec 5;10(1):868. doi: 10.1038/s41597-023-02726-7.
5
Comparing the Acceptance of Mobile Hypertension Apps for Disease Management Among Patients Versus Clinical Use Among Physicians: Cross-sectional Survey.比较患者对用于疾病管理的移动高血压应用程序的接受度与医生的临床使用情况:横断面调查。
JMIR Cardio. 2022 Jan 6;6(1):e31617. doi: 10.2196/31617.
Dtsch Arztebl Int. 2014 Sep 19;111(38):629-38. doi: 10.3238/arztebl.2014.0629.